This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

2024 ASCO® Annual Meeting Insights Hub
B

ASCO® 2024 Insights: "EXPEL-PANC - A Ph2 Study of BXCL701 + Pembro in mPDAC"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Benjamin Weinberg
By 2024 ASCO® Annual Meeting Insights Hub FEATURING Benjamin Weinberg
1 view
June 6, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

15:07
Exelixis

Safety and Efficacy Data of a TKI Monotherapy in HCC

Feat. J. Mizrahi

Featured Video

20:00
Exelixis

Child-Pugh Classification and its Role in Treatment Decisions in Pat…

Feat. P. Gholam

2024 ASCO® Annual Meeting Insights Hub: GI Videos

08:08
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Atezo + Bev as 1L Systemic Therapy for aH…

Feat. M. Storandt
09:25
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Expert Panel Discussion on CRC Including T…

Feat. N. Uboha, K. Spencer, M. Cecchini
12:50
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "The GIANT Trial (EA2186) - Gem & nab-…

Feat. E. Dotan
View All

Related Content

AUTOPLAY
27:37
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates

Feat. N. Uboha, A. Turk, K. Spencer, M. Cecchini
23:58
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Key Studies

Feat. R. Kim, R. Mehta
12:50
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "The GIANT Trial (EA2186) - Gem & nab-…

Feat. E. Dotan
20:07
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "GI Expert Panel Discussion on Key Trials I…

Feat. Y. Janjigian, S. Cytryn, S. Maron
06:47
UCSF School of Medicine

Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+…

Feat. H. Kang
06:03
Total Health

2024 Updates on Targeted Approaches for GI Cancers and New Data in N…

Feat. A. Grothey
17:05
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Advancing GI Cancer Treatment - The Clinic…

Feat. S. Cohen
03:50
UCLA Health

Perspectives on the Recent FDA Approval of NALIRIFOX in Frontline Me…

Feat. Z. Wainberg
12:08
Yale Cancer Center

GI Oncology Year in Review: Precision Medicine Update in Metastatic …

Feat. J. Lacy
07:53
Total Health

Updates on Pancreatic Cancer - 2023 ASCO® Direct Philadelphia

Feat. D. Lin
10:53
Yale Cancer Center

GI Oncology Year in Review: Metastatic Pancreatic Cancer - NAPOLI-3 …

Feat. J. Lacy
34:01
MedNews Week

Latest Treatment Strategies and Standard of Care for Pancreatic Canc…

Feat. M. Pishvaian
06:28
Shubham Pant

FDA Approval of Liposomal Irinotecan/NALIRIFOX in 1L Metastatic Panc…

22:10
Yale Cancer Center

Pancreatic Cancer Updates From Yale Cancer Center

Feat. J. Lacy
18:35
Rachna Shroff

Augmenting Standard Treatment Options in Pancreatic Cancer

17:02
Harshabad Singh

Targeting KRAS in Pancreatic Cancer

04:25
ecancer

ASCO® 2024 Insights: "Summary of the PASS-01 Trial - 1L FOLFIRI…

Feat. J. Knox
21:13
Integrity Continuing Education

Current Management of Locally Advanced Pancreatic Cancer

Feat. A. Narang
09:09
Integrity Continuing Education

DNA Damage Repair Deficiency in Pancreatic Cancer: Case Presentation…

Feat. N. Zaidi, K. Reiss Binder
06:16
ecancer

ASCO® 2023 Insights: "NAPOLI 3 Analysis of 1L NALIRIFOX vs. Gem…

Feat. E. O’Reilly